Evidence map›Paper›PMID 38286829›Full record

ReviewNature cancer2024

Aneuploidy and complex genomic rearrangements in cancer evolution.

Toby M Baker, Sara Waise, Maxime Tarabichi, Peter Van Loo

Open access · hybridAbstract readReview
In one paragraph

Review in Nature cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. It's a kind of MAGIC: uncovering the origins of chromosomal instability.Signal transduction and targeted therapy · 2026
    Article
  7. Genetic landscape of cancer: mechanisms, key genes, and therapeutic implications.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  8. Article
  9. Article
  10. EMT and cancer stem cells: Drivers of therapy resistance and promising therapeutic targets.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2025
    Review
  11. Article
  12. The Hallmarks of Aneuploidy in Cancer and Congenital Syndromes.Annual review of genomics and human genetics · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Toby M Baker *The Francis Crick Institute, London, UK.
Sara Waise *The Francis Crick Institute, London, UK.ORCID 0000-0003-0929-3121
Maxime TarabichiThe Francis Crick Institute, London, UK.
Peter Van LooThe Francis Crick Institute, London, UK. pvanloo@mdanderson.org.ORCID 0000-0003-0292-1949
The University of Texas MD Anderson Cancer Center · USThe Francis Crick Institute · GBUniversité Libre de Bruxelles · BE

Funding

Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RR210006Medical Research Council CC2008Wellcome Trust CC2008
6 · The paper itself

Abstract

Mutational processes that alter large genomic regions occur frequently in developing tumors. They range from simple copy number gains and losses to the shattering and reassembly of entire chromosomes. These catastrophic events, such as chromothripsis, chromoplexy and the formation of extrachromosomal DNA, affect the expression of many genes and therefore have a substantial effect on the fitness of the cells in which they arise. In this review, we cover large genomic alterations, the mechanisms that cause them and their effect on tumor development and evolution.

Indexed as

Chromosome AberrationsNeoplasmsAneuploidyGenomeGenomicsHumans

Identifiers

PMID38286829
PMCPMC7616040
OpenAlexW4391322178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.